Claritev Gross Profit 2019-2026 | CTEV

Claritev gross profit from 2019 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Claritev Annual Gross Profit
(Millions of US $)
2025 $712
2024 $691
2023 $726
2022 $876
2021 $942
2020 $619
2019 $833
2018 $891
Claritev Quarterly Gross Profit
(Millions of US $)
2026-06-30 $190
2026-03-31 $176
2025-12-31 $176
2025-09-30 $184
2025-06-30 $181
2025-03-31 $171
2024-12-31 $175
2024-09-30 $170
2024-06-30 $172
2024-03-31 $174
2023-12-31 $183
2023-09-30 $182
2023-06-30 $179
2023-03-31 $182
2022-12-31 $187
2022-09-30 $197
2022-06-30 $240
2022-03-31 $251
2021-12-31 $252
2021-09-30 $244
2021-06-30 $232
2021-03-31 $215
2020-12-31 $181
2020-09-30 $76
2020-06-30 $155
2020-03-31 $207
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.618B $0.965B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.014B 42.92
Tempus AI (TEM) United States $11.225B 0.00
10x Genomics (TXG) United States $9.135B 0.00
Hinge Health (HNGE) United States $7.649B 73.48
Hims & Hers Health (HIMS) United States $6.722B 0.00
Doximity (DOCS) United States $4.704B 29.00
Heartflow (HTFL) United States $4.308B 0.00
IRhythm Holdings (IRTC) United States $3.782B 249.39
Clover Health Investments (CLOV) United States $2.709B 0.00
Privia Health (PRVA) United States $2.667B 99.43
Inspire Medical Systems (INSP) United States $2.149B 32.74
Butterfly Network (BFLY) United States $1.973B 0.00
Schrodinger (SDGR) United States $1.532B 0.00
Omnicell (OMCL) United States $1.524B 21.76
Azenta (AZTA) United States $1.404B 76.29
Enovis (ENOV) United States $1.051B 5.44
Talkspace (TALK) United States $0.879B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.659B 0.00
Phreesia (PHR) United States $0.647B 34.73
Veradigm (MDRX) United States $0.593B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Evolent Health (EVH) United States $0.464B 0.00
Carlsmed (CARL) United States $0.419B 0.00
Senseonics Holdings (SENS) United States $0.370B 0.00
CapsoVision (CV) United States $0.326B 0.00
Standard BioTools (LAB) United States $0.273B 0.00
American Well (AMWL) United States $0.230B 0.00
KORU Medical Systems (KRMD) United States $0.144B 0.00
Health Catalyst (HCAT) United States $0.137B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.132B 0.00
CareCloud (CCLD) United States $0.089B 6.53
Pulmonx (LUNG) United States $0.085B 0.00
Zepp Health (ZEPP) Netherlands $0.065B 0.00
Nyxoah SA (NYXH) Belgium $0.062B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
Outset Medical (OM) United States $0.059B 0.00
EUDA Health Holdings (EUDA) Singapore $0.050B 0.00
Precipio (PRPO) United States $0.049B 0.00
MDxHealth SA (MDXH) Belgium $0.035B 0.00
111 (YI) China $0.031B 0.00
Evaxion - (EVAX) Denmark $0.026B 0.00
HeartBeam (BEAT) United States $0.023B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
HeartSciences (HSCS) United States $0.014B 0.00
Healthcare Triangle (HCTI) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.009B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
DataMeds AI (MEDS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
Zhongchao (ZCMD) China $0.001B 0.00
TruBridge (TBRG) United States $0.000B 0.00